There is a critical difference between the burden of disease and an investable healthcare market. Building and operating a successful specialty facility requires strong procedure volume, reliable payer coverage, access to specialists, and long-term capacity utilization.
Massive global prevalence across oncology, cardiology, and orthopaedics proves high demand, but scale alone is an insufficient investment thesis.
The core challenge for investors is identifying the specific specialties where true addressable demand meets sustainable operating economics.
Three specialties, three investment cases
The demand story differs materially by specialty.
- Oncology: Cancer incidence is rising, but treatment availability remains uneven. IARC projects annual cases to reach 35 million by 2050, 77% above 2022 levels.
- Cardiology: Cardiovascular disease creates sustained demand, but advanced cardiac services can require substantial investment in cath labs, imaging, critical care and specialist teams.
- Orthopedics: Musculoskeletal conditions affect a very broad population, creating demand across joint replacement, trauma, spine care and rehabilitation, with some procedures increasingly suited to ambulatory models.
These differences make specialty-level analysis more useful than simply ranking diseases by prevalence.
Disease burden is not investable demand
A large patient population creates potential demand. It does not establish a business case.
Diagnosis rates, insurance coverage, affordability, physician availability and treatment-seeking behaviour determine whether clinical need becomes actual utilization.
A market with high cancer incidence but limited ability to pay may be less attractive for a private oncology facility than a smaller market with strong insurance coverage and established referral flows.
The relevant equation is therefore volume + economics + competitive positioning, rather than disease prevalence alone.
Infrastructure can determine the commercial ceiling
Specialty hospitals can have very different capital and operating requirements.
An oncology platform may need radiation therapy, advanced imaging, pathology and chemotherapy capabilities.
Advanced cardiac care can require cath labs, operating theatres and intensive-care support. Orthopedic facilities may require surgical capacity, implants and rehabilitation.
The investment question is whether expected procedure volumes can support those fixed requirements.
That requires analysis of case mix, procedure volumes, pricing, payer mix, specialist availability and expected utilization before the facility footprint is determined.
Competition needs to be assessed at service level
Hospital counts can conceal the real competitive landscape.
A city may have numerous hospitals but limited comprehensive oncology services. Another may have several cardiology departments but only a few providers capable of advanced interventional procedures.
Competitive assessment should therefore examine service depth, physician capability, technology, utilization, pricing, payer segments and referral relationships.
The objective is to establish how differentiated a new specialty facility could realistically be, rather than simply measuring how many hospitals already operate in the market.
Patient flows can expand the addressable market
Specialty hospitals often draw patients from beyond their immediate locality.
Patients may travel across cities or regions for cancer treatment, complex cardiac procedures or specialist surgery. For a proposed facility, this means the relevant market may extend well beyond its immediate population.
Catchment analysis can combine patient origin, travel time, referral networks and competitor capabilities to determine whether demand is primarily local or regional.
This can materially influence both site selection and facility scale.
The facility model should follow the specialty
A specialty opportunity does not automatically require a new full-service hospital.
Ambulatory surgery, specialty institutes, diagnostic centres and specialty wings within existing hospitals can serve patient segments with different capital requirements.
OECD data shows that ambulatory surgery already accounts for 90% or more of cataract procedures in most OECD countries with available data.
The investment decision should therefore assess the specialty and delivery model together.
How Nexdigm’s Specialty Hospital Market Assessment Works
Nexdigm evaluates market viability across four key layers:
- Demand & Economic Feasibility: Sizes the addressable patient and procedure pool rather than relying only on disease prevalence, testing viability across payer mix, pricing, case volumes, and utilization.
- Clinical Ecosystem & Differentiation: Evaluates the required clinical infrastructure (specialists, equipment, diagnostics, and operating capacity) while benchmarking local competitors to identify strategic differentiation.
- Catchment & Referral Mapping: Analyzes patient flows and referral dynamics to determine realistic market reach and patient capture potential.
- Investment & Delivery Modeling: Translates findings into a tailored business case, comparing models such as dedicated specialty hospitals, institutes, ambulatory centers, or existing facility expansions.
Nexdigm’s Specialty Hospital Assessment
Nexdigm evaluated four regional markets for a planned 150-bed facility network for a private multi-specialty healthcare group. Prioritizing high-demand specialty lines indicated a 22% increase in projected revenue potential, 18% optimization in capital deployment, and projected financial break even within four years.
A specialty hospital opportunity should be judged by more than disease prevalence.
Patient volume, service economics, clinical capability and competitive positioning determine whether a specialty can support sustainable expansion. A specialty hospital market assessment helps investors identify where these conditions align and select the facility model best suited to the opportunity.
To take the next step, simply visit our Request a Consultation page and share your requirements with us.
Harsh Mittal
+91-8422857704
[email protected]